1. Home
  2. ALLT vs RCEL Comparison

ALLT vs RCEL Comparison

Compare ALLT & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLT
  • RCEL
  • Stock Information
  • Founded
  • ALLT 1996
  • RCEL N/A
  • Country
  • ALLT Israel
  • RCEL United States
  • Employees
  • ALLT N/A
  • RCEL N/A
  • Industry
  • ALLT Telecommunications Equipment
  • RCEL Medical/Dental Instruments
  • Sector
  • ALLT Telecommunications
  • RCEL Health Care
  • Exchange
  • ALLT Nasdaq
  • RCEL Nasdaq
  • Market Cap
  • ALLT 229.8M
  • RCEL 240.6M
  • IPO Year
  • ALLT 2006
  • RCEL N/A
  • Fundamental
  • Price
  • ALLT $6.34
  • RCEL $6.97
  • Analyst Decision
  • ALLT Buy
  • RCEL Strong Buy
  • Analyst Count
  • ALLT 1
  • RCEL 4
  • Target Price
  • ALLT $13.00
  • RCEL $17.25
  • AVG Volume (30 Days)
  • ALLT 227.3K
  • RCEL 197.1K
  • Earning Date
  • ALLT 05-12-2025
  • RCEL 05-08-2025
  • Dividend Yield
  • ALLT N/A
  • RCEL N/A
  • EPS Growth
  • ALLT N/A
  • RCEL N/A
  • EPS
  • ALLT N/A
  • RCEL N/A
  • Revenue
  • ALLT $92,195,000.00
  • RCEL $71,661,000.00
  • Revenue This Year
  • ALLT $6.43
  • RCEL $62.33
  • Revenue Next Year
  • ALLT $5.83
  • RCEL $30.59
  • P/E Ratio
  • ALLT N/A
  • RCEL N/A
  • Revenue Growth
  • ALLT N/A
  • RCEL 41.35
  • 52 Week Low
  • ALLT $2.02
  • RCEL $6.90
  • 52 Week High
  • ALLT $9.44
  • RCEL $14.16
  • Technical
  • Relative Strength Index (RSI)
  • ALLT 58.17
  • RCEL 28.06
  • Support Level
  • ALLT $5.61
  • RCEL $9.50
  • Resistance Level
  • ALLT $6.32
  • RCEL $9.85
  • Average True Range (ATR)
  • ALLT 0.31
  • RCEL 0.53
  • MACD
  • ALLT 0.05
  • RCEL -0.20
  • Stochastic Oscillator
  • ALLT 91.92
  • RCEL 10.03

About ALLT Allot Ltd.

Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. It has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: